Cargando…

Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants

Detalles Bibliográficos
Autores principales: Zheng, Qianqian, Duan, Liangwei, Jiang, Zhihua, Gu, Tingxuan, Zhang, Bojie, Li, Jiaoyang, Zhang, Yang, Zhang, Shiyu, Liang, Yinming, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170589/
https://www.ncbi.nlm.nih.gov/pubmed/35694375
http://dx.doi.org/10.1016/j.gendis.2022.05.027
_version_ 1784721464202625024
author Zheng, Qianqian
Duan, Liangwei
Jiang, Zhihua
Gu, Tingxuan
Zhang, Bojie
Li, Jiaoyang
Zhang, Yang
Zhang, Shiyu
Liang, Yinming
Wang, Hui
author_facet Zheng, Qianqian
Duan, Liangwei
Jiang, Zhihua
Gu, Tingxuan
Zhang, Bojie
Li, Jiaoyang
Zhang, Yang
Zhang, Shiyu
Liang, Yinming
Wang, Hui
author_sort Zheng, Qianqian
collection PubMed
description
format Online
Article
Text
id pubmed-9170589
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Chongqing Medical University
record_format MEDLINE/PubMed
spelling pubmed-91705892022-06-07 Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants Zheng, Qianqian Duan, Liangwei Jiang, Zhihua Gu, Tingxuan Zhang, Bojie Li, Jiaoyang Zhang, Yang Zhang, Shiyu Liang, Yinming Wang, Hui Genes Dis Rapid Communication Chongqing Medical University 2022-06-07 /pmc/articles/PMC9170589/ /pubmed/35694375 http://dx.doi.org/10.1016/j.gendis.2022.05.027 Text en © 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Rapid Communication
Zheng, Qianqian
Duan, Liangwei
Jiang, Zhihua
Gu, Tingxuan
Zhang, Bojie
Li, Jiaoyang
Zhang, Yang
Zhang, Shiyu
Liang, Yinming
Wang, Hui
Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants
title Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants
title_full Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants
title_fullStr Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants
title_full_unstemmed Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants
title_short Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants
title_sort two human monoclonal sars-cov-2 antibodies that maintain neutralizing potency against the sars-cov-2 omicron ba.1 and ba.2 variants
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170589/
https://www.ncbi.nlm.nih.gov/pubmed/35694375
http://dx.doi.org/10.1016/j.gendis.2022.05.027
work_keys_str_mv AT zhengqianqian twohumanmonoclonalsarscov2antibodiesthatmaintainneutralizingpotencyagainstthesarscov2omicronba1andba2variants
AT duanliangwei twohumanmonoclonalsarscov2antibodiesthatmaintainneutralizingpotencyagainstthesarscov2omicronba1andba2variants
AT jiangzhihua twohumanmonoclonalsarscov2antibodiesthatmaintainneutralizingpotencyagainstthesarscov2omicronba1andba2variants
AT gutingxuan twohumanmonoclonalsarscov2antibodiesthatmaintainneutralizingpotencyagainstthesarscov2omicronba1andba2variants
AT zhangbojie twohumanmonoclonalsarscov2antibodiesthatmaintainneutralizingpotencyagainstthesarscov2omicronba1andba2variants
AT lijiaoyang twohumanmonoclonalsarscov2antibodiesthatmaintainneutralizingpotencyagainstthesarscov2omicronba1andba2variants
AT zhangyang twohumanmonoclonalsarscov2antibodiesthatmaintainneutralizingpotencyagainstthesarscov2omicronba1andba2variants
AT zhangshiyu twohumanmonoclonalsarscov2antibodiesthatmaintainneutralizingpotencyagainstthesarscov2omicronba1andba2variants
AT liangyinming twohumanmonoclonalsarscov2antibodiesthatmaintainneutralizingpotencyagainstthesarscov2omicronba1andba2variants
AT wanghui twohumanmonoclonalsarscov2antibodiesthatmaintainneutralizingpotencyagainstthesarscov2omicronba1andba2variants